 Shares of Adagene Inc. ADAG, 1.10 jumped 11.2 in premarket trading on Wednesday after it announced a licensing and commercialization deal with Sanofi SNY, -2.65 that is worth up to 2.5 billion. U.S.-listed shares of Sanofi were down 1.5. 